FRM
HZNP
Fox Run Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-9,468
| Closed | -$586K | – | 963 |
|
|
2022
Q3 | $586K | Buy |
9,468
+2,254
| +31% | +$140K | 0.23% | 119 |
|
|
2022
Q2 | $575K | Buy |
7,214
+3,993
| +124% | +$318K | 0.29% | 94 |
|
|
2022
Q1 | $339K | Buy |
+3,221
| New | +$339K | 0.19% | 224 |
|
|
2020
Q4 | – | Sell |
-3,598
| Closed | -$279K | – | 312 |
|
|
2020
Q3 | $279K | Buy |
+3,598
| New | +$279K | 0.7% | 51 |
|
|
2019
Q2 | – | Sell |
-18,449
| Closed | -$488K | – | 717 |
|
|
2019
Q1 | $488K | Buy |
+18,449
| New | +$488K | 0.28% | 108 |
|
|
2018
Q4 | – | Sell |
-24,264
| Closed | -$475K | – | 849 |
|
|
2018
Q3 | $475K | Buy |
+24,264
| New | +$475K | 0.21% | 194 |
|
|
2018
Q2 | – | Sell |
-28,727
| Closed | -$408K | – | 1028 |
|
|
2018
Q1 | $408K | Buy |
28,727
+9,527
| +50% | +$135K | 0.1% | 387 |
|
|
2017
Q4 | $280K | Buy |
19,200
+3,400
| +22% | +$49.6K | 0.08% | 485 |
|
|
2017
Q3 | $200K | Sell |
15,800
-10,800
| -41% | -$137K | 0.06% | 610 |
|
|
2017
Q2 | $316K | Buy |
+26,600
| New | +$316K | 0.11% | 388 |
|
|
2017
Q1 | – | Sell |
-12,000
| Closed | -$194K | – | 828 |
|
|
2016
Q4 | $194K | Buy |
+12,000
| New | +$194K | 0.1% | 437 |
|